Literature DB >> 21661055

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Irene Litvan1, Dag Aarsland, Charles H Adler, Jennifer G Goldman, Jaime Kulisevsky, Brit Mollenhauer, Maria C Rodriguez-Oroz, Alexander I Tröster, Daniel Weintraub.   

Abstract

There is controversy regarding the definition and characteristics of mild cognitive impairment in Parkinson's disease. The Movement Disorder Society commissioned a Task Force to critically evaluate the literature and determine the frequency and characteristics of Parkinson's disease-mild cognitive impairment and its association with dementia. A comprehensive PubMed literature review was conducted using systematic inclusion and exclusion criteria. A mean of 26.7% (range, 18.9%-38.2%) of nondemented patients with Parkinson's disease have mild cognitive impairment. The frequency of Parkinson's disease-mild cognitive impairment increases with age, disease duration, and disease severity. Impairments occur in a range of cognitive domains, but single domain impairment is more common than multiple domain impairment, and within single domain impairment, nonamnestic is more common than amnestic impairment. A high proportion of patients with Parkinson's disease-mild cognitive impairment progress to dementia in a relatively short period of time. The primary conclusions of the Task Force are that: (1) Parkinson's disease-mild cognitive impairment is common, (2) there is significant heterogeneity within Parkinson's disease-mild cognitive impairment in the number and types of cognitive domain impairments, (3) Parkinson's disease-mild cognitive impairment appears to place patients at risk of progressing to dementia, and (4) formal diagnostic criteria for Parkinson's disease-mild cognitive impairment are needed.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21661055      PMCID: PMC3181006          DOI: 10.1002/mds.23823

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  109 in total

1.  Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study.

Authors:  N Klepac; V Trkulja; M Relja; T Babić
Journal:  Eur J Neurol       Date:  2008-02       Impact factor: 6.089

2.  Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.

Authors:  Natasa Klepac; Sanja Hajnsek; Vladimir Trkulja
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-12-08       Impact factor: 2.680

3.  Mental symptoms in Parkinson's disease are important contributors to caregiver distress.

Authors:  D Aarsland; J P Larsen; K Karlsen; N G Lim; E Tandberg
Journal:  Int J Geriatr Psychiatry       Date:  1999-10       Impact factor: 3.485

4.  The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease.

Authors:  David J Gill; Arielle Freshman; Jennifer A Blender; Bernard Ravina
Journal:  Mov Disord       Date:  2008-05-15       Impact factor: 10.338

5.  Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.

Authors:  B Pillon; B Deweer; Y Agid; B Dubois
Journal:  Arch Neurol       Date:  1993-04

6.  A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations.

Authors:  Gabriella Santangelo; Luigi Trojano; Carmine Vitale; Marta Ianniciello; Marianna Amboni; Dario Grossi; Paolo Barone
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

7.  Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Authors:  Connie Marras; Michael P McDermott; Paula A Rochon; Caroline M Tanner; Gary Naglie; Anthony E Lang
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

8.  Maternal stress induces synaptic loss and developmental disabilities of offspring.

Authors:  A Hayashi; M Nagaoka; K Yamada; Y Ichitani; Y Miake; N Okado
Journal:  Int J Dev Neurosci       Date:  1998 Jun-Jul       Impact factor: 2.457

9.  A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Authors:  Cindy Zadikoff; Susan H Fox; David F Tang-Wai; Teri Thomsen; Rob M A de Bie; Pettarusup Wadia; Janis Miyasaki; Sarah Duff-Canning; Anthony E Lang; Connie Marras
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

10.  Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia.

Authors:  Roy C Martin; Ozioma C Okonkwo; Joni Hill; H Randall Griffith; Kristen Triebel; Alfred Bartolucci; Anthony P Nicholas; Ray L Watts; Natividad Stover; Lindy E Harrell; David Clark; Daniel C Marson
Journal:  Mov Disord       Date:  2008-10-15       Impact factor: 10.338

View more
  218 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Sentence processing in Lewy body spectrum disorder: the role of working memory.

Authors:  Rachel G Gross; Corey T McMillan; Keerthi Chandrasekaran; Michael Dreyfuss; Sharon Ash; Brian Avants; Philip Cook; Peachie Moore; David J Libon; Andrew Siderowf; Murray Grossman
Journal:  Brain Cogn       Date:  2012-01-02       Impact factor: 2.310

Review 3.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

4.  Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease.

Authors:  Kurt Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2011-09-30       Impact factor: 3.575

5.  Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Jennifer G Goldman; Holly Weis; Glenn Stebbins; Bryan Bernard; Christopher G Goetz
Journal:  Mov Disord       Date:  2012-07-06       Impact factor: 10.338

6.  Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.

Authors:  Eileen E Moran; Cuiling Wang; Mindy Katz; Laurie Ozelius; Alison Schwartz; Jelena Pavlovic; Roberto A Ortega; Richard B Lipton; Molly E Zimmerman; Rachel Saunders-Pullman
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

Review 7.  The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging.

Authors:  Nicola J Ray; Antonio P Strafella
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

Review 8.  Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.

Authors:  Barbara Connolly; Susan H Fox
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

9.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

10.  Demonstration of Early Cognitive Impairment in Parkinson's Disease with Visual P300 Responses.

Authors:  Gülin Özmüş; Deniz Yerlikaya; Arife Gökçeoğlu; Derya Durusu Emek Savaş; Raif Çakmur; Beril Dönmez Çolakoğlu; Görsev G Yener
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.